Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
NCT03402893Phase 4Completed
- Sponsor
- DermResearch
- Start
- Jul 2017
- Primary completion
- Nov 2017
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clindamycin + benzoyl peroxide in acne vulgaris, Post-inflammatory hyperpigmentation (PIH), sponsored by DermResearch. Started Jul 2017; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne vulgarisPost-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on NCT03402893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402893.